XJPX
3951
Market cap115mUSD
Oct 09, Last price
883.00JPY
1D
0.11%
1Q
0.00%
Jan 2017
-32.62%
IPO
129.35%
Name
Asahi Printing Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Asahi Printing Co.,Ltd. specializes in producing and distributing a wide range of printing and packaging solutions tailored for the pharmaceutical and cosmetics industries, primarily operating within Japan. The company's offerings encompass packaging for over-the-counter medications, prescription drugs, pharmaceutical roll labels, informational leaflets, and cosmetic items. Furthermore, it provides various packaging machinery, including systems for blister packing, liquid filling, banding, pillow packaging, automated processes, diverse inspection functions, and corrugated box packaging for shipping and palletizing. Founded in 1872, the firm's headquarters are located in Toyama, Japan.
Key people
Jugo Asahi
Chairman of the Board, Representative Director · since 2010
Yoshihiro Nishida
Director of Finance, Director · since 2025
Toshiyuki Hirota
Vice President, Chief Director of Administration, Representative Director · since 2025
Kazuhito Sato
Managing Director, Chief Director of Production · since 2023
Shotaro Sasaki
Chief Director of West Japan Sales, Director of Toyama Sales, Manager of Sales Planning Office, Director · since 2024
Shigenori Asahi
President, Representative Director · since 2021
Hideyuki Hogi
Chief Director of East Japan Sales, Manager of Shinjuku Office, Director · since 2025
Takeshi Tsukada
Director · since 2025
Kazuhito Wakabayashi
Director · since 2025
Satoru Mizunami
Independent Director · since 2016
Yumi Oyukawa
Independent Director · since 2024
Tadanao Takata
Independent Director · since 2015
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||